Do cystic fibrosis patients on azithromycin need electrocardiogram monitoring?

Sharpton, Rachel; Condren, Michelle; O'Neal, Katherine; Lloyd, Ann; McIntosh, Heather

Sharpton, Rachel; Condren, Michelle; O'Neal, Katherine; Lloyd, Ann; McIntosh, Heather.

Afiliación

Sharpton R; University of Oklahoma College of Pharmacy, 4502 E. 41st Street, Tulsa, OK 74135, United States. Electronic address: sharpton01@gmail.com.
Condren M; University of Oklahoma College of Pharmacy and School of Community Medicine, 4502 E. 41st St, Tulsa, OK 74135, United States.
O'Neal K; University of Oklahoma College of Pharmacy and School of Community Medicine, 4502 E. 41st Street, Tulsa, OK 74135, United States.
Lloyd A; University of Oklahoma College of Pharmacy, 4502 E. 41st Street, Tulsa, OK 74135, United States.
McIntosh H; University of Oklahoma School of Community Medicine, 4502 E. 41st Street, Tulsa, OK 74135, United States.

Pulm Pharmacol Ther ; 43: 55-56, 2017 04.

Article en En | MEDLINE | ID: mdl-28219728

Asunto(s)

Antibacterianos/uso terapéutico; Azitromicina/uso terapéutico; Fibrosis Quística/tratamiento farmacológico; Adolescente; Antibacterianos/efectos adversos; Azitromicina/efectos adversos; Monitoreo de Drogas/métodos; Electrocardiografía/métodos; Femenino; Humanos; Masculino; Estudios Retrospectivos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Azitromicina / Fibrosis Quística / Antibacterianos Tipo de estudio: Observational_studies Límite: Adolescent / Female / Humans / Male Idioma: En Revista: Pulm Pharmacol Ther Asunto de la revista: FARMACOLOGIA Año: 2017 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google